About Hetero Life Sciences Private Limited
Data last updated:
Hetero Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 January 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2007PTC052262.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Hetero Life Scinces Private Limited. It is led by directors Bandi Vamsikrishna and Srinivas Reddy Male.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No.8 – 3 – 166/7/1 Second Floor Erragadda, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.29 Lakh. For the same year it recorded a net loss of ₹2.61 Lakh (net margin -202.6%) and EBITDA of -₹2.61 Lakh (EBITDA margin -202.6%). Revenue has declined at a compounded annual rate (CAGR) of 19% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website heterodrugs.com.
Company details
CIN history
Hetero Life Sciences has one previous CIN (Corporate Identification Number): U73100AP2007PTC052262. The current CIN is U73100TG2007PTC052262, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2007PTC052262 | Current |
| U73100AP2007PTC052262 | Previous |
Contact details
Hetero Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is heterodrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No.8 – 3 – 166/7/1 Second Floor Erragadda, Hyderabad, Telangana, India – 500018
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hetero Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Hetero Life Sciences Private Limited
FY 2024 filings availableHetero Life Sciences Private Limited reported revenue of ₹1.29 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -202.6% | ||||
| Net Profit Margin | -202.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hetero Life Sciences Private Limited, buy the company report.
Board of directors of Hetero Life Sciences Private Limited
Hetero Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bandi Vamsikrishna | Director | 05 Jan 2007 | 19 Years 9 Months | Current |
| Srinivas Reddy Male Also directs: Idhant Estate Properties LLP, Daaruk Infratech LLP, Krishna Sahithi Reddy Properties LLP and 5 more | Director | 05 Jan 2007 | 19 Years 9 Months | Current |
Peer comparison
Hetero Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the Consumer Services industry (Professional Services), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Petroleo Services India Private Limited | ₹1.31 Lakh (FY 2024) | -99.0% | Delhi, India | |||
| Dreamcoat Surface Finishining System Pvt Ltd | ₹1.3 Lakh (FY 2024) | 4292.0% | Thiruvananthapuram, Kerala, India | |||
| Jplumino India Private Limited | ₹1.29 Lakh (FY 2019) | -83.0% | Delhi, India | |||
| Bench Bio Private Limited | ₹1.29 Lakh (FY 2025) | 352.0% | Valvad, Gujarat, India | |||
| Asakari Services Private Limited | ₹1.29 Lakh (FY 2018) | Katihar, Bihar, India | ||||
| Hetero Life Sciences Private Limitedthis company | ₹1.29 Lakh (FY 2024) | -₹2.61 Lakh | -202.6% | Hyderabad, Telangana, India | ||
| Pragtisheel Marketing Private Limited | ₹1.29 Lakh (FY 2025) | 4.0% | Delhi, India | |||
| Al-Falah Medical Research Foundation | ₹1.28 Lakh (FY 2024) | -3.0% | New Delhi, Delhi, India | |||
| Gainwell Leasing Private Limited | ₹1.28 Lakh (FY 2024) | 6.0% | New Delhi, Delhi, India | |||
| Vexillum Certification and Inspection Private Limited | ₹1.28 Lakh (FY 2024) | -38.0% | Delhi, India | |||
| Blink Design Private Limited | ₹1.28 Lakh (FY 2024) | -21.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Hetero Life Sciences Private Limited, buy the company report.
Auditor
Hetero Life Sciences Private Limited is audited by M V Narayana Reddy & Co for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M V Narayana Reddy & Co | FY 2022 | 002370S |
Shareholding
The shareholding of Hetero Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hetero Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hetero Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hetero Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hetero Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hetero Life Sciences Private Limited has 5 board changes on record since 2007: 3 appointments and 2 cessations. The latest: Chandra Sekhar Tumuluru was appointed as Director on 19 Jul 2024.
Frequently asked questions
Hetero Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 January 2007 (19+ years old) and is registered under CIN U73100TG2007PTC052262.
Hetero Life Sciences has 2 current directors:
- Bandi Vamsikrishna - Director
- Srinivas Reddy Male - Director
The latest financial statements of Hetero Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Hetero Life Sciences is U73100TG2007PTC052262. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hetero Life Sciences was incorporated on 05 January 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Hetero Life Sciences by revenue are Petroleo Services India Private Limited, Dreamcoat Surface Finishining System Pvt Ltd, Jplumino India Private Limited, Bench Bio Private Limited, Asakari Services Private Limited and 5 more, all in the Consumer Services industry (Professional Services).
Chandra Sekhar Tumuluru was appointed as Director on 19 Jul 2024. Chandra Sekhar Tumuluru ceased to be Additional Director on 25 May 2016. Parthasaradhi Reddy Bandi ceased to be Director on 31 Mar 2015. Hetero Life Sciences has 5 board changes on record in total.
Hetero Life Sciences can be reached through the website heterodrugs.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Hetero Life Sciences is at H.No.8 – 3 – 16671 Second Floor Erragadda, Hyderabad, Telangana, India – 500018.
Hetero Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Hetero Life Sciences is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.